FindTrial
Sign In

Analysis of expression of CD44 and podocalyxin in head and neck cancer

Analysis of expression of CD44 and podocalyxin in head and neck cancer - Analysis of expression of CD44 and podocalyxin in head and neck cancer

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000017742
Enrollment
50
Registered
2015-06-01
Start date
2012-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer

Interventions

None listed

Sponsors

Kumamoto University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Head and neck cancer

Exclusion criteria

Exclusion criteria: patient who reject joining in this trial

Design outcomes

Primary

MeasureTime frame
Expression of CD44 and podocalyxin in head and neck cancer—

Countries

Japan

Contacts

Public ContactDaizo Murakami

Kumamoto University Graduate School of Medicine Department of Otolaryngology-Head and Neck Surgery

daizo-m@fc.kuh.kumamoto-u.ac.jp096-373-5255

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026